By Patrick Wingrove and Sriparna Roy Oct 29 (Reuters) - Eli Lilly raised its full-year revenue forecast by $5 billion and ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

Popular weight loss medications such as Ozempic and Wegovy have transformed the way millions of Americans manage obesity, ...

By Patrick Wingrove Oct 29 (Reuters) - Eli Lilly raised its full-year revenue forecast and beat third-quarter earnings ...

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as ...

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...

Coverage of GLP-1 drugs for weight loss is being dropped by many employer-sponsored healthcare plans as premiums soar, though ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Health Ministry warns that unapproved peptides marketed for weight loss, bodybuilding and anti-aging could damage the liver ...

So, we're back with 31 more firsthand accounts about the unexpected ways GLP-1s have affected people's lives beyond the ...

From Sunday anyone weighing more than 19st 7Ib (124kg) will be banned from flying to an offshore platform.

Before his GLP-1 weight-loss journey, Charles Barkley faced a major setback when hip surgery left him inactive for months.